• Developed the portfolio for Vitabiotics, positioning and creating value propositions for products in the gynecology and pediatrics fields.• As a subject matter expert, I led the go-to-market strategy and crafted a long-term innovation roadmap.• Translated the midterm product roadmap into concrete product specifications for implementation by sales teams, completed the entire lifecycle management process of interacting with KOLs, and planned the launch of new products.• Prepared various sales training materials and advertising materials.Achievements: • Dominated the nutraceutical Mkt with a 40% SOM in 2022, generated a total revenue of 600 million EGP.• Uphold for Fetal Programming for pregnant females, by provided technical support, and education to Gynecologists by stressing on the superiority of every Vitabiotics brand along with putting the quality in the center of approach. • Developed the Rehlet Hamel campaign to provide social support & education for pregnant women, regardless of their demographic and social background. The campaign's aimed to help pregnant acquire appropriate knowledge and develop healthy attitudes towards pregnancy. We screened 300K pregnant females, which is approximately 10% of all pregnant women.

NPP Primary Responsibilities:• Informed commercialization plan for new products.• Conducted market analyses, designed market research process, and identified relevant clinical and landscape data to inform asset strategies and BD opportunities. • Successfully launched 4 brands.Brand Manager Essential Responsibilities:- Launched and managed MP Gynecology Specialty line.- Shaped and maximized Gynecology & Commercial portfolios.- Developed effective brand plans.- Responsible for product training and KOL management.- Organized and supported large-scale/national events.

• During my tenure at Virology BU, I had the privilege of spearheading the successful launch of Gilead's HCV In-Country License in Egypt. • My role encompassed developing and executing innovative sales strategies, fostering meaningful collaborations with key stakeholders, conducting insightful market research, and driving synergies across the organization. • Alongside leading a talented nationwide sales team, I meticulously monitored performance metrics, crafted sales forecasts, and ensured adherence to the company's ethical and policy guidelines.• Achievements: I achieved a sales target of 100M EGP in two years. screened more than one million people under the auspices of the 100 Million Health campaign, in cooperation with the Hepatitis Virus Committee in its national survey plan to detect and treat Hepatitis C, and in partnership with NGOs and representatives of the People's Assembly. I also succeeded in eliminating Virus C in assigned MOH accounts areas.

I have been given the responsibility of managing the Neuroscience portfolio business (Zyprexa, Cymbalta, Strattera, and Prozac) in Giza and Upper Egypt.

Managed Bone Portfolio (Osteocerin, Foltac, and Cataflam amp.) in Shobra and Shobra El Khima.